Skip to main content
. 2020 Jan 13;15(1):e0227595. doi: 10.1371/journal.pone.0227595

Fig 3. Trends in visits of specific classes of glaucoma drugs and prescribing patterns from 2013 to 2017.

Fig 3

(A) Trends of prostaglandin analogues; (B) Trends of β-receptor antagonists; (C) Trends in the prescribing patterns of glaucoma drugs.